Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/0hVUaAV2obA/264557.php
Friday, 9 August 2013
Biomarker identified to predict immune response risk after stem cell transplants
Researchers from Indiana University, the University of Michigan, the Fred Hutchinson Cancer Research Center and the Dana-Farber Cancer Institute have identified and validated a biomarker accessible in blood tests that could be used to predict which stem cell transplant patients are at highest risk for a potentially fatal immune response called graft-versus-host disease...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment